Heydebreck CSV. Biomarkers and methods for determining efficacy of anti-EGFR antibodies in cancer therapy. Merck Patent GmbH: French. 2012.
Herszenyi L, Tulassay ZJERMPS. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 2010; 14(4): 249-58.
Hamzehzadeh L, Yousefi M, Ghaffari S-H. Colorectal cancer screening: A comprehensive review to recent non-invasive methods. Int J Hematol Oncol Stem Cell Res 2017; 11(3): 250-61.
Testa U, Pelosi E, Castelli GJMS. Colorectal cancer: Genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. Med Sci (Basel) 2018; 6(2): 31.
Shull AY, Latham-Schwark A, Ramasamy P, et al. Novel somatic mutations to PI3K pathway genes in metastatic melanoma. PloS One 2012; 7(8): e43369.
Saddiq M, Kankara A, Dutsin-Ma UA.
Prevalence of Rifampicin Mono Resistant
among patients Attending Federal Medical Centre, Katsina, Nigeria. SJMLS 2017; 2(1): 90-4.
Cirillo G, Puoci FF, Parisi OI, Curcio M, Spizzirri UG, Picci N. Imprinted hydrophilic nanospheres as drug delivery systems for 5-fluorouracil sustained release. Drug Target 2009; 17(1): 72-7.
Ichikawa W, Ooyama A, Toda E, et al. Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin. Cancer Chemother Pharmacol 2006; 58(6): 794-801.
Danenberg PV, Malli H, Swenson S. Thymidylate synthase inhibitors. Semin Oncol 1999; 26(6): 621-31.
Garabalino MA, Hughes AM, Molinari AJ, et al. Boron Neutron Capture Therapy (BNCT) for the treatment of liver metastases: Biodistribution studies of boron compounds in an experimental model. Radiat Environ Biophys 2011; 50(1): 199-207.
Poste G, Kirsh R. Site-specific (targeted) drug delivery in cancer therapy. Nat Biotechnol 1983; 1(10): 869-78.
Tummala S, Satish Kumar MN, Prakash A. Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer. Saudi Pharm J 2015; 23(3): 308-14.
Tığlı Aydın RS, Pulat M. 5-Fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: Evaluation of controlled release kinetics. J Nanomater 2012; 2012: 313961.
Kingsley JD, Dou H, Morehead J, Rabinow B, Gendelman HE, Destache CJ. Nanotechnology: A focus on nanoparticles as a drug delivery system. 2006; 1(3): 340-50.
Pounder RJ, Dove APJPC. Towards poly (ester) nanoparticles: Recent advances in the synthesis of functional poly (ester) s by ring-opening polymerization. Polym Chem 2010; 1(3): 260-71.
Zidan OH. PEGylated chitosan/doxorubicin nanoparticles and conjugated with monoclonal antibodies for breast cancer therapy MS Dissertation American University in Cairo, Egypt. June, 2020.
Uskoković V, Uskoković DP. Nanotechnologies in preventive and regenerative medicine: Quo Vadis, Domine? Nanotechnologies in preventive and regenerative medicine Elsevier. 2018; pp. pp. 513-566.
Brekke OH, Sandlie I. Therapeutic antibodies for human diseases at the dawn of the twenty-first century. Nat Rev Drug Discov 2003; 2(1): 52-62.
Wee P, Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers (Basel) 2017; 9(5): 52.
Bertani MF. Analysis of ErbB2-and growth factor dependent gene expression in breast cells. PhD Dissertation United Kingdom University of London, University College London,. 2006.
Jaiswal BS, Seshagiri S. ERBB3 mutations in cancer. US20130195870, 2013.
Harnish DC, Zhang S, Jin MX. Methods and compositions for selective inhibition of ligand binding to the lectin-like receptor for oxidized low density lipoprotein (LOX-1). US20090311271, 2009.
Berezowska S. Targeting heterodimeric EGFR/ErbB2-receptor complexes with novel bispecific small-molecule tyrosine kinase inhibitors in combination with an experimental radiotherapy in human malignant glioma cells. PhD Dissertation, Technische Universität München, Germany, 2009.
Basu S, Harfouche R, Soni S, Sengupta S. Polymeric nanoparticles with enhanced drug-loading and methods of use thereof. US20120052041, 2012.
Kuo Y-C, Ko H-F. Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles. Biomaterials 2013; 34(20): 4818-30.
Yang G-J, Huang J-L, Meng W-J, Shen M, Jiao X-A.
A reusable capacitive immunosensor for detection of
spp. based on grafted ethylene diamine and self-assembled gold nanoparticle monolayers.
Anal Chim Acta 2009; 647(2): 159-66.
Liu Y, Wang W, Yang J, Zhou C, Sun J. pH-sensitive polymeric micelles triggered drug release for extracellular and intracellular drug targeting delivery. Asian J Pharm Sci 2013; 8(3): 159-67.
Bilodeau MT, Kadiyala S, Shinde R, White B, Wooster R, Barder TE. Targeted conjugates encapsulated in particles and formulations thereof. US20140187501, 2014.
Cheng J, Tong R. Nanoconjugates and nanoconjugate formulations. US9295651 2016.
Singh A, Singh S, Gupta AK, Kulkani GM. Pharmaceutical composition comprising at least one anticancer drug and at least one polymer. CN101495148, 2012.
Radosz M, Xu P, Shen Y. Nanoparticles for cytoplasmic drug delivery to cancer cells. US8945629, 2015.
Nair KL, Jagadeeshan S, Nair SA, Kumar GS. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Int J Nanomedicine 2011; 6: 1685-97.
Kwan YP, Saito T, Ibrahim D, et al. Evaluation of the cytotoxicity, cell-cycle arrest, and apoptotic induction by Euphorbia hirta in MCF-7 breast cancer cells. Pharm Biol 2016; 54(7): 1223-36.
Suhail SM, Woo KT, Tan HK, Wong KS. Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) of urinary protein in acute kidney injury. Saudi J Kidney Dis Transpl 2011; 22(4): 739-45.
D’Alessandro A, Liumbruno G, Grazzini G, Zolla L. Red blood cell storage: The story so far. Blood Transfus 2010; 8(2): 82-8.
Au JL, Walker JS, Rustum Y. Pharmacokinetic studies of 5-fluorouracil and 5′-deoxy-5-fluorouridine in rats. J Pharmacol Exp Ther 1983; 227(1): 174-80.
Wang G-H, Wang J, Qi W, Chen Y, Sun L-X. Tissue distribution and excretion of 5-fluorouracil from indomethacin 5-fluorouracil-1-ylmethylester in rats. Yao Xue Xue Bao 2008; 43: 81-5.
Allen DC. Oesophageal carcinoma. Histopathology Reporting Springer. 2013; pp. pp. 3-13.